公开(公告)号：US20050170965A1

公开(公告)日：2005-08-04

申请号：US10502475

申请日：2003-01-28

Applicant: Valerio Bramati ,  Joel Coret ,  Scott Edwards ,  Paul Gioia

Inventor： Valerio Bramati ,  Joel Coret ,  Scott Edwards ,  Paul Gioia

IPC: A01N25/16 ,  A01N57/18 ,  A01N57/20

CPC classification number: A01N57/20 ,  A01N25/30 ,  A01N2300/00

Abstract: The present invention concerns an aqueous phytopathological formulation comprising a hydrosoluble salt of at least one aminophosphate or aminophosphonate type herbicide; at least one principal surfactant selected from alkylbetaines and alkyl(amidoalkyl)betaines, and at least one additive selected from at least one of the following compounds: (i) amines or etheramines comprising at least one hydrocarbon radical containing 2 to 24 carbon atoms, optionally polyalkoxylated; (ii) acid or non acid phosphate mono- or di-esters, optionally polyalkoxylated; (iii) alkali metal, alkaline-earth metal, ammonium, alkylammonium, alkanolammonium, iron, zinc or manganese salts of a mineral acid; and (iv) alkylmonoglycosides or alkylpolyglycosides.

Abstract translation: 本发明涉及包含至少一种氨基磷酸酯或氨基膦酸酯类除草剂的水溶性盐的水性植物病理制剂; 选自烷基甜菜碱和烷基（酰氨基烷基）甜菜碱的至少一种主要表面活性剂和至少一种选自以下化合物中的至少一种的添加剂：（i）包含至少一个含有2至24个碳原子的烃基的胺或醚胺，任选地 聚烷氧基化 （ii）酸或非酸性磷酸酯单酯或二酯，任选聚烷氧基化; （iii）无机酸的碱金属，碱土金属，铵，烷基铵，链烷醇铵，铁，锌或锰盐; 和（iv）烷基单糖苷或烷基聚糖苷。

公开(公告)号：US06524554B1

公开(公告)日：2003-02-25

申请号：US09285280

申请日：1999-04-02

Applicant: David Scott Edwards ,  Milind Rajopadhye

Inventor： David Scott Edwards ,  Milind Rajopadhye

IPC: A61K4904

CPC classification number: C07K7/06 ,  A61K51/088

Abstract: The present invention provides novel radiopharmaceuticals comprising one to three pentapeptides, X1X2X3X4X5, independently attached to a metal chelator or bonding moiety, Ch, to which is attached a Tc-99m, Re-186, or Re-188, optionally further comprising a linking group, Ln, between-the peptides and the chelator or bonding moiety. The pentapeptide sequence binds to the tuftsin receptor and is attached at the N-terminus to Ln or Ch. These radiopharmaceuticals are useful for the diagnosis of infection and inflammation, reagents and kits useful for preparing the radiopharmaceuticals, methods of imaging sites of infection and/or inflammation in a patient, and methods of diagnosing diseases associated with infection or inflammation in patients in need of such diagnosis.

Abstract translation: 本发明提供了包含一至三个五肽X1X2X3X4X5的新型放射性药物，其独立地连接到金属螯合剂或结合部分Ch上，其连接有Tc-99m，Re-186或Re-188，任选地还包含连接基团 ，Ln，肽与螯合剂或结合部分之间。 五肽序列与簇绒蛋白受体结合，并在N末端连接至Ln或Ch。 这些放射性药物可用于感染和炎症的诊断，可用于制备放射性药物的试剂和试剂盒，成像患者感染和/或炎症部位的成像方法，以及诊断与感染或炎症有关的疾病的方法 这样的诊断。

公开(公告)号：US06218926B1

公开(公告)日：2001-04-17

申请号：US09219923

申请日：1998-12-22

Applicant: Scott Edwards May

Inventor： Scott Edwards May

IPC: H01F2726

CPC classification number: H01F27/266

Abstract: A magnetic core assembly and method of assembling a magnetic core assembly. The core assembly includes laminated magnetic core tightly clamped together by a pair of unitized flanged clamps. Each unitized flanged clamp has a generally flat surface and a peripheral flange. The generally flat surface defines at least one opening for receiving a coil and a number of holes adjacent the opening for receiving assembly hardware. The core is assembled by placing a first one of the two unitized flanged clamps, flange down on a generally horizontal work surface. Alignment pins are placed in one or more of the assembly hardware apertures adjacent the coil opening. The segments of the first core lamination are slidably placed on the alignment pins such that they lie on the flat surface of the first unitized flange clamp. The segments of each remaining core lamination are slidably placed on the alignment pins until the required number of laminations have been installed. After the final lamination is installed, the second of the two unitized flanged clamps is placed on the final core lamination, flat surface down, the alignment pins are removed and assembly hardware is installed and tightened.

Abstract translation: 磁芯组件和组装磁芯组件的方法。 芯组件包括通过一对组合法兰的夹具紧密地夹在一起的层压磁芯。 每个组合的法兰夹具具有大致平坦的表面和外围法兰。 大致平坦的表面限定了至少一个用于接收线圈的开口和邻近开口的用于接收组件硬件的多个孔。 通过将两个组合的带凸缘的夹具中的第一个凸缘放置在大致水平的工作表面上来将芯体组装。 对准销放置在与线圈开口相邻的一个或多个组件硬件孔中。 第一芯层压件的段可滑动地放置在对准销上，使得它们位于第一组合法兰夹的平坦表面上。 每个剩余芯层压板的段可滑动地放置在对准销上，直到已经安装所需数量的叠片。 在安装最终层压之后，将两个组合的法兰夹具中的第二个放置在最终的芯层压板上，平坦的表面向下，对准销被移除并且组装硬件被安装和紧固。

公开(公告)号：US6013721A

公开(公告)日：2000-01-11

申请号：US176499

申请日：1998-10-21

Applicant: Donald Craig Schall ,  Steven Scott Edwards

Inventor： Donald Craig Schall ,  Steven Scott Edwards

IPC: C09D5/00 ,  B05D5/02 ,  C08L33/06 ,  C08L33/14 ,  C08L39/00 ,  C09D133/12 ,  C09D133/14 ,  C09D157/04 ,  E01F9/08 ,  F21V7/00

CPC classification number: C09D133/14 ,  C09D133/12 ,  C09D5/004 ,  E01F9/576 ,  C08L33/06 ,  C08L33/14

Abstract: The present invention is directed to traffic paint compositions, which dry faster than conventional waterborne traffic paints and to a method of producing traffic paint road markings made therefrom. The traffic paint composition of the present invention includes a blend of an anionically stabilized polymer binder, a polyfunctional amine polymer having an amine and an acid functionality therein and an amount of volatile base sufficient to raise the pH of the composition to a point where essentially all of the polyfunctional amine polymer is in a non-ionic state. The traffic paint composition of the present invention further provides improved storage stability.

Abstract translation: 本发明涉及交通油漆组合物，其干燥速度比常规水性交通油漆干燥速度快，并且涉及一种生产交通油漆道路标线的方法。 本发明的交通油漆组合物包括阴离子稳定的聚合物粘合剂，具有胺的多官能胺聚合物和其酸官能团的共混物和足以将组合物的pH升高到基本上全部的点的挥发性碱的量 的多官能胺聚合物处于非离子状态。 本发明的交通油漆组合物进一步提供了改进的储存稳定性。

公开(公告)号：US5861188A

公开(公告)日：1999-01-19

申请号：US879496

申请日：1997-05-22

Applicant: Donald Craig Schall ,  Steven Scott Edwards

Inventor： Donald Craig Schall ,  Steven Scott Edwards

IPC: C09D5/00 ,  B05D5/02 ,  C08L33/06 ,  C08L33/14 ,  C08L39/00 ,  C09D133/12 ,  C09D133/14 ,  C09D157/04 ,  E01F9/08 ,  F21V7/00

CPC classification number: C09D133/14 ,  C09D133/12 ,  C09D5/004 ,  E01F9/576 ,  C08L33/06 ,  C08L33/14

Abstract: The present invention is directed to traffic paint compositions, which dry faster than conventional waterborne traffic paints and to a method of producing traffic paint road markings made therefrom. The traffic paint composition of the present invention includes a blend of an anionically stabilized polymer binder, a polyfunctional amine polymer having an amine and an acid functionality therein and an amount of volatile base sufficient to raise the pH of the composition to a point where essentially all of the polyfunctional amine polymer is in a non-ionic state. The traffic paint composition of the present invention further provides improved storage stability.

Abstract translation: 本发明涉及交通油漆组合物，其干燥速度比常规水性交通油漆干燥速度快，并且涉及一种生产交通油漆道路标线的方法。 本发明的交通油漆组合物包括阴离子稳定的聚合物粘合剂，具有胺的多官能胺聚合物和其酸官能团的共混物和足以将组合物的pH升高到基本上全部的点的挥发性碱的量 的多官能胺聚合物处于非离子状态。 本发明的交通油漆组合物进一步提供了改进的储存稳定性。

公开(公告)号：US5750088A

公开(公告)日：1998-05-12

申请号：US476296

申请日：1995-06-07

Applicant: Michael Sworin ,  Milind Rajopadhye ,  Thomas David Harris ,  David Scott Edwards ,  Edward Hollister Cheesman ,  Shuang Liu

Inventor： Michael Sworin ,  Milind Rajopadhye ,  Thomas David Harris ,  David Scott Edwards ,  Edward Hollister Cheesman ,  Shuang Liu

IPC: A61K31/00 ,  A61K38/12 ,  A61K49/04 ,  A61K51/00 ,  A61K51/04 ,  A61K51/08 ,  C07B59/00 ,  C07D213/82 ,  C07D257/00 ,  C07D259/00 ,  C07D277/60 ,  C07D401/00 ,  C07D401/12 ,  C07D401/14 ,  C07D413/12 ,  C07K5/10 ,  C07K5/103 ,  C07K7/64 ,  C07K14/75 ,  C07K17/02 ,  A61K38/00

CPC classification number: C07D213/82 ,  A61K51/04 ,  A61K51/082 ,  A61K51/088 ,  C07B59/008 ,  C07D401/12 ,  C07D401/14 ,  C07K14/75 ,  A61K2123/00

Abstract: This invention provides novel reagents for the preparation of radiopharmaceuticals useful as imaging agents for the diagnosis of cardiovascular disorders, infection, inflammation and cancer, diagnostic kits comprising said reagents and intermediate compounds useful for the preparation of said reagents. The reagents are comprised of stable hydrazone modified biologically active molecules that react with gamma emitting radioisotopes to form radiopharmaceuticals that selectively localize at sites of disease and thus allow an image to be obtained of the loci using gamma scintigraphy.

Abstract translation: 本发明提供用于制备用作诊断心血管疾病，感染，炎症和癌症的成像剂的放射性药物的新型试剂，包含所述试剂的诊断试剂和可用于制备所述试剂的中间体化合物。 试剂由稳定的腙修饰的生物活性分子组成，其与γ发射放射性同位素反应形成放射性药物，其选择性地定位在疾病部位，从而允许使用γ闪烁扫描获得基因座的图像。

公开(公告)号：US10329614B2

公开(公告)日：2019-06-25

申请号：US14909582

申请日：2014-08-01

Applicant: STC.UNM ,  Jeremy Scott Edwards

Inventor： Jeremy Scott Edwards

IPC: C12Q1/68 ,  C12Q1/6874 ,  C12Q1/6825 ,  C12Q1/6841

Abstract: This disclosure describes, in one aspect, methods for DNA sequencing and performing epigenomic analyses. Generally, the methods include immobilizing a plurality of copies of a DNA molecule on a surface, stretching at least a portion of the immobilized DNA molecules, and sequencing at least a portion of the immobilized, stretched DNA molecules.

公开(公告)号：US09397907B1

公开(公告)日：2016-07-19

申请号：US13789565

申请日：2013-03-07

Applicant: William Scott Edwards ,  Teresa Aguilera

Inventor： William Scott Edwards ,  Teresa Aguilera

IPC: G06F15/173 ,  H04L12/26

CPC classification number: H04L67/1095 ,  G06F11/079 ,  G06F11/1461 ,  G06F11/3006 ,  G06F11/3055 ,  G06F11/324 ,  G06F2201/81 ,  H04L43/08 ,  H04L67/16

Abstract: Systems, methods, and media that provide backup protection statuses for computing devices are provided herein. Some methods may include determining a backup status for a first computing device, assigning a protection status for the first computing device based upon a comparison of the backup status and a compliance schema for the first computing device, and transmitting the protection status to a monitoring device utilized by an end user.

Abstract translation: 本文提供了为计算设备提供备份保护状态的系统，方法和介质。 一些方法可以包括确定第一计算设备的备份状态，基于备份状态与第一计算设备的合规性模式的比较来为第一计算设备分配保护状态，并将保护状态发送到监视设备 由最终用户使用。

公开(公告)号：US20160168632A1

公开(公告)日：2016-06-16

申请号：US14909582

申请日：2014-08-01

Applicant: Jeremy Scott EDWARDS ,  STC.UNM

Inventor： Jeremy Scott Edwards

IPC: C12Q1/68

CPC classification number: C12Q1/6874 ,  C12Q1/6825 ,  C12Q1/6841 ,  C12Q2523/303 ,  C12Q2543/10 ,  C12Q2523/307

Abstract: This disclosure describes, in one aspect, methods for DNA sequencing and performing epigenomic analyses. Generally, the methods include immobilizing a plurality of copies of a DNA molecule on a surface, stretching at least a portion of the immobilized DNA molecules, and sequencing at least a portion of the immobilized, stretched DNA molecules.

Abstract translation: 本公开在一个方面描述了用于DNA测序和进行表观基因组分析的方法。 通常，所述方法包括将多个拷贝的DNA分子固定在表面上，拉伸固定的DNA分子的至少一部分，以及测序至少一部分固定的，拉伸的DNA分子。

公开(公告)号：US20140047081A1

公开(公告)日：2014-02-13

申请号：US13570161

申请日：2012-08-08

Applicant: William Scott Edwards

Inventor： William Scott Edwards

IPC: G06F15/177

CPC classification number: H04L41/0806 ,  G06F11/1464 ,  G06F11/1484 ,  G06F11/2023 ,  G06F11/203 ,  G06F2201/84 ,  G06F2201/85 ,  G06Q10/10 ,  H04L61/1511 ,  H04L61/2015 ,  H04L63/0272 ,  H04L67/10 ,  H04L69/40

Abstract: Cloud-based virtual machines and offices are provided herein. Methods may include establishing a cloud-based virtual office, by providing selections, corresponding to backups of servers of a computing network, to a user interface, establishing a cloud gateway for the virtual office, virtualizing a backup for each server using a virtualization program to create the cloud-based virtual office that includes virtual server machines networked with one another via the cloud gateway, and providing a workload to the cloud-based virtual office.

Abstract translation: 本文提供了基于云的虚拟机和办公室。 方法可以包括通过将与计算网络的服务器的备份相对应的选择提供给用户界面来建立基于云的虚拟办公室，为虚拟办公室建立云网关，使用虚拟化程序虚拟化每个服务器的备份， 创建基于云的虚拟办公室，其中包括通过云网关彼此联网的虚拟服务器机器，并为基于云的虚拟办公室提供工作负载。